Compare CADL & PMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CADL | PMO |
|---|---|---|
| Founded | 1999 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 339.8M | 291.4M |
| IPO Year | 2021 | N/A |
| Metric | CADL | PMO |
|---|---|---|
| Price | $6.35 | $10.50 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $19.43 | N/A |
| AVG Volume (30 Days) | ★ 960.7K | 99.0K |
| Earning Date | 11-13-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.10% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.42 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $24.38 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.25 | $8.57 |
| 52 Week High | $13.68 | $10.68 |
| Indicator | CADL | PMO |
|---|---|---|
| Relative Strength Index (RSI) | 72.12 | 59.10 |
| Support Level | $5.39 | $10.31 |
| Resistance Level | $6.83 | $10.62 |
| Average True Range (ATR) | 0.36 | 0.09 |
| MACD | 0.22 | 0.01 |
| Stochastic Oscillator | 80.81 | 64.71 |
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
Putnam Municipal Opportunities Trust is a non-diversified closed-end management investment company. It seeks to provide as high a level of current income free from federal income tax as Putnam Management believes is consistent with the preservation of capital. The fund invests in healthcare, utilities, transportation, tax bonds, local debt, state debt, and education.